These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6794901)

  • 21. Angioimmunoblastic lymphadenopathy with dysproteinemia: report of a case in infancy with review of literature.
    de Terlizzi M; Toma MG; Santostasi T; Colella R; Ceci A; De Benedictis G
    Pediatr Hematol Oncol; 1989; 6(1):37-44. PubMed ID: 2701700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia.
    Ohshima KHaraoka S; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
    Leuk Lymphoma; 2000 Aug; 38(5-6):541-5. PubMed ID: 10953975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angioimmunoblastic lymphadenopathy].
    Campo E
    Med Clin (Barc); 1990 Jun; 95(3):97-9. PubMed ID: 2250528
    [No Abstract]   [Full Text] [Related]  

  • 24. Angioimmunoblastic lymphadenopathy with dysproteinemia. Immunohistologic and ultrastructural studies.
    Valdes AJ; Blair OM
    Am J Clin Pathol; 1976 Sep; 66(3):551-9. PubMed ID: 1085561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal model of human disease. Angioimmunoblastic lymphadenopathy with dysproteinemia.
    Gindhart TD; Greenspan JS
    Am J Pathol; 1980 Jun; 99(3):805-8. PubMed ID: 6966894
    [No Abstract]   [Full Text] [Related]  

  • 26. [Angioimmunoblastic lymphadenopathy. 3 cases with polyclonal gammopathy].
    Hofmann V; Zimmermann A; Morell A
    Schweiz Med Wochenschr; 1979 Jun; 109(24):897-903. PubMed ID: 451510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.
    Bräuninger A; Spieker T; Willenbrock K; Gaulard P; Wacker HH; Rajewsky K; Hansmann ML; Küppers R
    J Exp Med; 2001 Oct; 194(7):927-40. PubMed ID: 11581315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Angioimmunoblastic lymphadenopathy].
    Bak M; Garam T; Bakács T; Döbrentey E; Bodó M; Petrányi G
    Morphol Igazsagugyi Orv Sz; 1981 Jan; 21(1):26-33. PubMed ID: 6973692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angioimmunoblastic lymphadenopathy: a study of the function of lymphocyte populations.
    Garam T; Bak M; Bakács T; Döbrentei E; Petrányi G
    Cancer; 1981 Jun; 47(12):2850-5. PubMed ID: 6973387
    [No Abstract]   [Full Text] [Related]  

  • 30. [Monoclonal immunoglobulinemias (M Ig)].
    Jarkowska-Kozłowska J
    Pol Arch Med Wewn; 1987 Jun; 77(6):306-16. PubMed ID: 3152128
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biclonal gammopathy in a patient with immunoblastic lymphadenopathy like T cell lymphoma].
    Murakami M; Sugiura K
    Rinsho Ketsueki; 1989 Jan; 30(1):116-21. PubMed ID: 2497263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferating cell population in angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) lesions analyzed by double immunoenzymatic staining and immunomolecular markers.
    Namikawa R; Takeshita M
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1644-51. PubMed ID: 2965845
    [No Abstract]   [Full Text] [Related]  

  • 33. [Angioimmunoblastic adenopathy with monoclonal gammopathy. Prognosis].
    Iori I; Tumiati B; Portioli I
    Nouv Presse Med; 1981 May; 10(23):1943. PubMed ID: 6787567
    [No Abstract]   [Full Text] [Related]  

  • 34. [Angioimmunoblastic lymphadenopathy (author's transl)].
    Rupniewska ZM
    Przegl Lek; 1980; 37(5):481-3. PubMed ID: 6999550
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of cellular immunology in malignant and benign monoclonal gammapathies].
    Gasparotto G; Semenzato G; Tosato F; Cazzaro G; Amadori G
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1823-5. PubMed ID: 1087754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An IgM pan-T monoclonal antibody that blocks E-rosette formation.
    De Nardin E; Tanigaki N
    Hybridoma; 1985; 4(2):125-41. PubMed ID: 3874145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angioimmunoblastic lymphadenopathy with dysproteinemia terminating in peripheral T cell lymphoma with cytotoxic/suppressor phenotype: a case report].
    Oishi H; Kabemura T; Ideguchi H; Nishimura J; Ibayashi H; Kaneko S; Takeshita M; Kikuchi M
    Rinsho Ketsueki; 1986 May; 27(5):792-7. PubMed ID: 2943912
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cytoplasmic immunoglobulins in lymph node cells in angioimmunoblastic lymphadenopathies].
    Merson AG
    Arkh Patol; 1980; 42(4):30-2. PubMed ID: 6772144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic value of monoclonal antibodies in immunophenotyping of angioimmunoblastic lymphadenopathy/lymphogranulomatosis X.
    Knecht H; Odermatt BF; Maurer R; Rüttner JR
    Br J Haematol; 1987 Sep; 67(1):19-24. PubMed ID: 3499172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Angioimmunoblastic lymphadenopathy, chemically induced and in autoimmune diseases. A common immunopathologic mechanism?].
    Scolozzi R; Boccafogli A; Tocchetto M; Lanza M; Cavazzini L; Guidoboni CA; Vicentini L; Salmi R; Coletti M; Pansini R
    Recenti Prog Med; 1983 Dec; 74(12):1385-94. PubMed ID: 6608773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.